The acute lung injury market is projected to reach US$ 741.98 million by 2028 from US$ 539.61 million in 2021; it is expected to grow at a CAGR of 4.7% from 2021 to 2028.
Increasing prevalence of respiratory diseases and rising geriatric population are driving the acute lung injury market. However, the high cost of therapies is hampering the market growth.
The degeneration of various cells or tissues with age leads to a greater risk of multiple diseases. Elderly people are more prone to get affected by the failure of organs such as the lungs, heart, and kidney. This is mainly ascribed to the changes in the composition and metabolic activities in the ecosystem of the aging human body. With the increasing age, the organ system efficiency decreases, leading to diseases such as respiratory diseases and other infections. Thus, ALI is correlated with increased morbidity and mortality in the aging population. Also, age is generally reported as a risk factor for the growth of acute respiratory distress syndrome (ARDS).
According to the statistics from the United Nations (UN) Global Population Prospects for 2019, the world population is projected to grow by two billion over the next 30 years, to reach 9.7 billion by 2050 from 7.7 billion in 2019, and the world's elderly population is already on the rise. Along with developed countries such as the US, Canada, UK, France, Germany, and Japan, developing countries such as China, India, and South Korea are experiencing significant growth in the geriatric population. The world's population is aging; over 65s are expected to account for 1 in 6 of the population by 2050, increasing from 1 in 11 in 2019. With a strong association between aging and increased incidence of diseases-including respiratory conditions such as chronic obstructive pulmonary disease and acute infection-thorough research on the impact of disease risk and severity will be necessary to manage the health of an ever-aging population effectively. The growth of the geriatric population in these countries is driven by improved healthcare facilities and better healthcare services, which has resulted in increased life expectancy. Thus, the growing aging population worldwide is among the major driving factors for the acute lung injury market.
Based on therapy, the acute lung injury market is segmented into mechanical ventilation, fluid management, pharmacotherapy, and adjunctive procedures. In 2021, the mechanical ventilation segment accounted for the largest market share in the global acute lung injury market. The segment's growth is attributed to the fact that mechanical ventilation in acute lung injury (ALI) aims to maintain oxygen while avoiding its toxicity and complications associated with the ventilation.
Based on end user, the acute lung injury market is segmented into hospitals, ambulatory surgery centers, and others. The hospitals segment is likely to hold the largest share of the market in 2021, and the same segment is anticipated to register the highest CAGR (4.9%) of the market during the forecast period.
National Institutes of Health (NIH), National Healthcare Service (NHS), Centers for Disease Control and Prevention (CDC), American Thoracic Society (ATS), National Center for Biotechnology Information, National Hospital Ambulatory Medical Care Survey: 2018, Canada Sepsis Foundation, World Bank Data, American Cardiology College, United Nations (UN), and World Health Organization (WHO) are among the major secondary sources referred to while preparing the report on the acute lung injury market.
Reasons to Buy
The degeneration of various cells or tissues with age leads to a greater risk of multiple diseases. Elderly people are more prone to get affected by the failure of organs such as the lungs, heart, and kidney. This is mainly ascribed to the changes in the composition and metabolic activities in the ecosystem of the aging human body. With the increasing age, the organ system efficiency decreases, leading to diseases such as respiratory diseases and other infections. Thus, ALI is correlated with increased morbidity and mortality in the aging population. Also, age is generally reported as a risk factor for the growth of acute respiratory distress syndrome (ARDS).
According to the statistics from the United Nations (UN) Global Population Prospects for 2019, the world population is projected to grow by two billion over the next 30 years, to reach 9.7 billion by 2050 from 7.7 billion in 2019, and the world's elderly population is already on the rise. Along with developed countries such as the US, Canada, UK, France, Germany, and Japan, developing countries such as China, India, and South Korea are experiencing significant growth in the geriatric population. The world's population is aging; over 65s are expected to account for 1 in 6 of the population by 2050, increasing from 1 in 11 in 2019. With a strong association between aging and increased incidence of diseases-including respiratory conditions such as chronic obstructive pulmonary disease and acute infection-thorough research on the impact of disease risk and severity will be necessary to manage the health of an ever-aging population effectively. The growth of the geriatric population in these countries is driven by improved healthcare facilities and better healthcare services, which has resulted in increased life expectancy. Thus, the growing aging population worldwide is among the major driving factors for the acute lung injury market.
Based on therapy, the acute lung injury market is segmented into mechanical ventilation, fluid management, pharmacotherapy, and adjunctive procedures. In 2021, the mechanical ventilation segment accounted for the largest market share in the global acute lung injury market. The segment's growth is attributed to the fact that mechanical ventilation in acute lung injury (ALI) aims to maintain oxygen while avoiding its toxicity and complications associated with the ventilation.
Based on end user, the acute lung injury market is segmented into hospitals, ambulatory surgery centers, and others. The hospitals segment is likely to hold the largest share of the market in 2021, and the same segment is anticipated to register the highest CAGR (4.9%) of the market during the forecast period.
National Institutes of Health (NIH), National Healthcare Service (NHS), Centers for Disease Control and Prevention (CDC), American Thoracic Society (ATS), National Center for Biotechnology Information, National Hospital Ambulatory Medical Care Survey: 2018, Canada Sepsis Foundation, World Bank Data, American Cardiology College, United Nations (UN), and World Health Organization (WHO) are among the major secondary sources referred to while preparing the report on the acute lung injury market.
Reasons to Buy
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the acute lung injury market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the global acute lung injury market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution
Table of Contents
1. Introduction1.1 Scope of the Study
1.2 The Publisher's Research Report Guidance
1.3 Market Segmentation
1.3.1 Global Acute Lung Injury Market - By Therapy
1.3.2 Global Acute Lung Injury Market - By End User
1.3.3 Global Acute Lung Injury Market - By Geography
2. Global Acute Lung Injury Market - Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Acute Lung Injury Market - Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 North America - PEST Analysis
4.2.2 Europe - PEST Analysis
4.2.3 Asia Pacific - PEST Analysis
4.2.4 Middle East and Africa - PEST Analysis
4.2.5 South and Central America (SCAM) - PEST Analysis
4.3 Experts Opinion
5. Acute Lung Injury Market - Key Market Dynamics
5.1 Market Drivers
5.1.1 Increasing Prevalence of Respiratory Diseases
5.1.1 Rising Geriatric Population
5.2 Market Restraints
5.2.1 High Cost of Therapies
5.3 Market Opportunities
5.3.1 Technological Advancements by Market Players
5.4 Future Trends
5.4.1 Growing Pipeline Drugs
5.5 Impact Analysis
6. Acute Lung Injury Market - Global Analysis
6.1 Global Acute Lung Injury Market Revenue Forecast and Analysis
6.2 Global Acute Lung Injury Market, By Geography - Forecast and Analysis
6.3 Market Positioning of Key Players
7. Acute Lung Injury Market Analysis and Forecast to 2028 - By Therapy
7.1 Overview
7.2 Acute Lung Injury Market Revenue Share, by Therapy (2021 and 2028)
7.3 Mechanical Ventilation
7.3.1 Overview
7.3.2 Mechanical Ventilation: Acute Lung Injury Market - Revenue and Forecast to 2028 (US$ Million)
7.4 Fluid Management
7.4.1 Overview
7.4.2 Fluid Management: Acute Lung Injury Market - Revenue and Forecast to 2028 (US$ Million)
7.5 Pharmacotherapy
7.5.1 Overview
7.5.2 Pharmacotherapy: Acute Lung Injury Market - Revenue and Forecast to 2028 (US$ Million)
7.6 Adjunctive Procedures
7.6.1 Overview
7.6.2 Adjunctive Procedures: Acute Lung Injury Market - Revenue and Forecast to 2028 (US$ Million)
8. Acute Lung Injury Market Analysis - By End-User
8.1 Overview
8.2 Acute Lung Injury Market Revenue Share, by End User (2021 and 2028)
8.3 Hospitals
8.3.1 Overview
8.3.2 Hospitals: Acute Lung Injury Market - Revenue and Forecast to 2028 (US$ Million)
8.4 Ambulatory Surgery Centers
8.4.1 Overview
8.4.2 Ambulatory Surgery Centers: Acute Lung Injury Market - Revenue and Forecast to 2028 (US$ Million)
8.5 Others
8.5.1 Overview
8.5.2 Others: Acute Lung Injury Market - Revenue and Forecast to 2028 (US$ Million)
9. Global Acute Lung Injury Market - Geographic Analysis
9.1 North America: Acute Lung Injury Market
9.1.1 Overview
9.1.2 North America: Acute Lung Injury Market - Revenue and Forecast to 2028 (USD Million)
9.1.3 North America Acute Lung Injury Market, by Therapy - Revenue and Forecast to 2028 (USD Million)
9.1.4 North America Acute Lung Injury Market, by End User - Revenue and Forecast to 2028 (USD Million)
9.1.5 North America: Acute Lung Injury Market, by Country, 2021 & 2028 (%)
9.1.5.1 US: Acute Lung Injury Market - Revenue and Forecast to 2028 (USD Million)
9.1.5.1.1 US: Acute Lung Injury Market - Revenue and Forecast to 2028 (USD Million)
9.1.5.1.2 US Acute Lung Injury Market, by Therapy - Revenue and Forecast to 2028 (USD Million)
9.1.5.1.3 US Acute Lung Injury Market, by End User - Revenue and Forecast to 2028 (USD Million)
9.1.5.2 Canada: Acute Lung Injury Market - Revenue and Forecast to 2028 (USD Million)
9.1.5.2.1 Canada: Acute Lung Injury Market - Revenue and Forecast to 2028 (USD Million)
9.1.5.2.2 Canada Acute Lung Injury Market, by Therapy - Revenue and Forecast to 2028 (USD Million)
9.1.5.2.3 Canada Acute Lung Injury Market, by End User - Revenue and Forecast to 2028 (USD Million)
9.1.5.3 Mexico: Acute Lung Injury Market - Revenue and Forecast to 2028 (USD Million)
9.1.5.3.1 Mexico: Acute Lung Injury Market - Revenue and Forecast to 2028 (USD Million)
9.1.5.3.2 Mexico Acute Lung Injury Market, by Therapy - Revenue and Forecast to 2028 (USD Million)
9.1.5.3.3 Mexico Acute Lung Injury Market, by End User - Revenue and Forecast to 2028 (USD Million)
9.2 Europe: Acute Lung Injury Market
9.2.1 Overview
9.2.2 Europe: Acute Lung Injury Market - Revenue and Forecast to 2028 (USD Million)
9.2.3 Europe: Acute Lung Injury Market, by Therapy, 2019-2028 (USD Million)
9.2.4 Europe: Acute Lung Injury Market, by End User, 2019-2028 (USD Million)
9.2.5 Europe: Acute Lung Injury Market, by Country, 2021 & 2028(%)
9.2.5.1 Germany: Acute Lung Injury Market - Revenue and Forecast to 2028 (USD Million)
9.2.5.1.1 Germany: Acute Lung Injury Market - Revenue and Forecast to 2028 (USD Million)
9.2.5.1.2 Germany: Acute Lung Injury Market, by Therapy, 2019-2028 (USD Million)
9.2.5.1.3 Germany: Acute Lung Injury Market, by End User, 2019-2028 (USD Million)
9.2.5.2 France: Acute Lung Injury Market - Revenue and Forecast to 2028 (USD Million)
9.2.5.2.1 France: Acute Lung Injury Market - Revenue and Forecast to 2028 (USD Million)
9.2.5.2.2 France: Acute Lung Injury Market, by Therapy, 2019-2028 (USD Million)
9.2.5.2.3 France: Acute Lung Injury Market, by End User, 2019-2028 (USD Million)
9.2.5.3 UK: Acute Lung Injury Market - Revenue and Forecast to 2028 (USD Million)
9.2.5.3.1 UK: Acute Lung Injury Market - Revenue and Forecast to 2028 (USD Million)
9.2.5.3.2 UK: Acute Lung Injury Market, by Therapy, 2019-2028 (USD Million)
9.2.5.3.3 UK: Acute Lung Injury Market, by End User, 2019-2028 (USD Million)
9.2.5.4 Italy: Acute Lung Injury Market - Revenue and Forecast to 2028 (USD Million)
9.2.5.4.1 Italy: Acute Lung Injury Market - Revenue and Forecast to 2028 (USD Million)
9.2.5.4.2 Italy: Acute Lung Injury Market, by Therapy, 2019-2028 (USD Million)
9.2.5.4.3 Italy: Acute Lung Injury Market, by End User, 2019-2028 (USD Million)
9.2.5.5 Spain: Acute Lung Injury Market - Revenue and Forecast to 2028 (USD Million)
9.2.5.5.1 Spain: Acute Lung Injury Market - Revenue and Forecast to 2028 (USD Million)
9.2.5.5.2 Spain: Acute Lung Injury Market, by Therapy, 2019-2028 (USD Million)
9.2.5.5.3 Spain: Acute Lung Injury Market, by End User, 2019-2028 (USD Million)
9.2.5.6 Rest of Europe: Acute Lung Injury Market - Revenue and Forecast to 2028 (USD Million)
9.2.5.6.1 Rest of Europe: Acute Lung Injury Market - Revenue and Forecast to 2028 (USD Million)
9.2.5.6.2 Rest of Europe: Acute Lung Injury Market, by Therapy, 2019-2028 (USD Million)
9.2.5.6.3 Rest of Europe: Acute Lung Injury Market, by End User, 2019-2028 (USD Million)
9.3 Asia Pacific: Acute Lung Injury Market
9.3.1 Overview
9.3.2 Asia Pacific: Acute Lung Injury Market - Revenue and Forecast to 2028 (USD Million)
9.3.3 Asia Pacific: Acute Lung Injury Market, by Therapy - Revenue and Forecast to 2028 (USD Million)
9.3.4 Asia Pacific: Acute Lung Injury Market, by End User, 2019-2028 (USD Million)
9.3.5 Asia Pacific: Acute Lung Injury Market, by Country, 2021 & 2028 (%)
9.3.5.1 China: Acute Lung Injury Market - Revenue and Forecast to 2028 (USD Million)
9.3.5.1.1 China: Acute Lung Injury Market - Revenue and Forecast to 2028 (USD Million)
9.3.5.1.2 China: Acute Lung Injury Market, by Therapy - Revenue and Forecast to 2028 (USD Million)
9.3.5.1.3 China: Acute Lung Injury Market, by End User, 2019-2028 (USD Million)
9.3.5.2 Japan: Acute Lung Injury Market - Revenue and Forecast to 2028 (USD Million)
9.3.5.2.1 Japan: Acute Lung Injury Market - Revenue and Forecast to 2028 (USD Million)
9.3.5.2.2 Japan: Acute Lung Injury Market, by Therapy - Revenue and Forecast to 2028 (USD Million)
9.3.5.2.3 Japan: Acute Lung Injury Market, by End User, 2019-2028 (USD Million)
9.3.5.3 India: Acute Lung Injury Market - Revenue and Forecast to 2028 (USD Million)
9.3.5.3.1 India: Acute Lung Injury Market - Revenue and Forecast to 2028 (USD Million)
9.3.5.3.2 India: Acute Lung Injury Market, by Therapy - Revenue and Forecast to 2028 (USD Million)
9.3.5.3.3 India: Acute Lung Injury Market, by End User, 2019-2028 (USD Million)
9.3.5.4 South Korea: Acute Lung Injury Market - Revenue and Forecast to 2028 (USD Million)
9.3.5.4.1 South Korea: Acute Lung Injury Market - Revenue and Forecast to 2028 (USD Million)
9.3.5.4.2 South Korea: Acute Lung Injury Market, by Therapy - Revenue and Forecast to 2028 (USD Million)
9.3.5.4.3 South Korea: Acute Lung Injury Market, by End User, 2019-2028 (USD Million)
9.3.5.5 Australia: Acute Lung Injury Market - Revenue and Forecast to 2028 (USD Million)
9.3.5.5.1 Australia: Acute Lung Injury Market - Revenue and Forecast to 2028 (USD Million)
9.3.5.5.2 Australia: Acute Lung Injury Market, by Therapy - Revenue and Forecast to 2028 (USD Million)
9.3.5.5.3 Australia: Acute Lung Injury Market, by End User, 2019-2028 (USD Million)
9.3.5.6 Rest of Asia Pacific: Acute Lung Injury Market - Revenue and Forecast to 2028 (USD Million)
9.3.5.6.1 Rest of Asia Pacific: Acute Lung Injury Market - Revenue and Forecast to 2028 (USD Million)
9.3.5.6.2 Rest of Asia Pacific: Acute Lung Injury Market, by Therapy - Revenue and Forecast to 2028 (USD Million)
9.3.5.6.3 Rest of Asia Pacific: Acute Lung Injury Market, by End User, 2019-2028 (USD Million)
9.4 Middle East and Africa: Acute Lung Injury Market
9.4.1 Overview
9.4.2 Middle East and Africa: Acute Lung Injury Market - Revenue and Forecast to 2028 (USD Million)
9.4.3 Middle East and Africa: Acute Lung Injury Market, by Therapy, 2019-2028 (USD Million)
9.4.4 Middle East and Africa: Acute Lung Injury Market, by End User, 2019-2028 (USD Million)
9.4.5 Middle East and Africa: Acute Lung Injury Market, by Country, 2021 & 2028 (%)
9.4.5.1 Saudi Arabia: Acute Lung Injury Market - Revenue and Forecast to 2028 (USD Million)
9.4.5.1.1 Saudi Arabia: Acute Lung Injury Market - Revenue and Forecast to 2028 (USD Million)
9.4.5.1.2 Saudi Arabia: Acute Lung Injury Market, by Therapy, 2019-2028 (USD Million)
9.4.5.1.3 Saudi Arabia: Acute Lung Injury Market, by End User, 2019-2028 (USD Million)
9.4.5.2 South Africa: Acute Lung Injury Market - Revenue and Forecast to 2028 (USD Million)
9.4.5.2.1 South Africa: Acute Lung Injury Market - Revenue and Forecast to 2028 (USD Million)
9.4.5.2.2 South Africa: Acute Lung Injury Market, by Therapy, 2019-2028 (USD Million)
9.4.5.2.3 South Africa: Acute Lung Injury Market, by End User, 2019-2028 (USD Million)
9.4.5.3 UAE: Acute Lung Injury Market - Revenue and Forecast to 2028 (USD Million)
9.4.5.3.1 UAE: Acute Lung Injury Market - Revenue and Forecast to 2028 (USD Million)
9.4.5.3.2 UAE: Acute Lung Injury Market, by Therapy, 2019-2028 (USD Million)
9.4.5.3.3 UAE: Acute Lung Injury Market, by End User, 2019-2028 (USD Million)
9.4.5.4 Rest of Middle East and Africa: Acute Lung Injury Market - Revenue and Forecast to 2028 (USD Million)
9.4.5.4.1 Rest of Middle East and Africa: Acute Lung Injury Market - Revenue and Forecast to 2028 (USD Million)
9.4.5.4.2 Rest of Middle East and Africa: Acute Lung Injury Market, by Therapy, 2019-2028 (USD Million)
9.4.5.4.3 Rest of Middle East and Africa: Acute Lung Injury Market, by End User, 2019-2028 (USD Million)
9.5 South and Central America: Acute Lung Injury Market
9.5.1 Overview
9.5.2 South and Central America: Acute Lung Injury Market - Revenue and Forecast to 2028 (USD Million)
9.5.3 South and Central America: Acute Lung Injury Market, by Therapy, 2019-2028 (USD Million)
9.5.4 South and Central America: Acute Lung Injury Market, by End User, 2019-2028 (USD Million)
9.5.5 South and Central America: Acute Lung Injury Market, by Country, 2021 & 2028 (%)
9.5.5.1 Brazil: Acute Lung Injury Market - Revenue and Forecast to 2028 (USD Million)
9.5.5.1.1 Brazil: Acute Lung Injury Market - Revenue and Forecast to 2028 (USD Million)
9.5.5.1.2 Brazil: Acute Lung Injury Market, by Therapy, 2019-2028 (USD Million)
9.5.5.1.3 Brazil: Acute Lung Injury Market, by End User, 2019-2028 (USD Million)
9.5.5.2 Argentina: Acute Lung Injury Market - Revenue and Forecast to 2028 (USD Million)
9.5.5.2.1 Argentina: Acute Lung Injury Market - Revenue and Forecast to 2028 (USD Million)
9.5.5.2.2 Argentina: Acute Lung Injury Market, by Therapy, 2019-2028 (USD Million)
9.5.5.2.3 Argentina: Acute Lung Injury Market, by End User, 2019-2028 (USD Million)
9.5.5.3 Rest of South and Central America: Acute Lung Injury Market - Revenue and Forecast to 2028 (USD Million)
9.5.5.3.1 Rest of South and Central America: Acute Lung Injury Market - Revenue and Forecast to 2028 (USD Million)
9.5.5.3.2 Rest of South and Central America: Acute Lung Injury Market, by Therapy, 2019-2028 (USD Million)
9.5.5.3.3 Rest of South and Central America: Acute Lung Injury Market, by End User, 2019-2028 (USD Million)
10. Impact Of COVID-19 Pandemic on Acute Lung Injury Market
10.1 North America: Impact Assessment of COVID-19 Pandemic
10.2 Europe: Impact Assessment of COVID-19 Pandemic
10.3 Asia Pacific: Impact Assessment of COVID-19 Pandemic
10.4 Middle East and Africa: Impact Assessment of COVID-19 Pandemic
10.5 South and Central America: Impact Assessment of COVID-19 Pandemic
11. Acute Lung Injury Market - Industry Landscape
11.1 Overview
11.2 Growth Strategies Done by the Companies in the Acute Lung Injury Market, (%)
11.3 Organic Developments
11.3.1 Overview
11.4 Inorganic Developments
11.4.1 Overview
12. Company Profiles
12.1 GlaxoSmithKline Plc
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Stemedica Cell Technologies, Inc
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Histocell
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 APEPTICO Forschung und Entwicklung GmbH
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Windtree Therapeutics, Inc.
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 ReAlta Life Sciences, Inc.
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Apeiron Biologics AG
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 Qx Therapeutics, Inc.
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 Angion
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments
12.10 Asklepion Pharmaceuticals, LLC.
12.10.1 Key Facts
12.10.2 Business Description
12.10.3 Products and Services
12.10.4 Financial Overview
12.10.5 SWOT Analysis
12.10.6 Key Developments
13. Appendix
13.1 About the Publisher
13.2 Glossary of TermsList of Tables
Table 1. North America Acute Lung Injury Market, by Therapy - Revenue and Forecast to 2028 (USD Million)
Table 2. North America Acute Lung Injury Market, by End User - Revenue and Forecast to 2028 (USD Million)
Table 3. US Acute Lung Injury Market, by Therapy - Revenue and Forecast to 2028 (USD Million)
Table 4. US Acute Lung Injury Market, by End User - Revenue and Forecast to 2028 (USD Million)
Table 5. Canada Acute Lung Injury Market, by Therapy -Revenue and Forecast to 2028 (USD Million)
Table 6. Canada Acute Lung Injury Market, by End User - Revenue and Forecast to 2028 (USD Million)
Table 7. Mexico Acute Lung Injury Market, by Therapy -Revenue and Forecast to 2028 (USD Million)
Table 8. Mexico Acute Lung Injury Market, by End User - Revenue and Forecast to 2028 (USD Million)
Table 9. Europe: Acute Lung Injury Market, by Therapy - Revenue and Forecast to 2028 (USD Million)
Table 10. Europe: Acute Lung Injury Market, by End User - Revenue and Forecast to 2028 (USD Million)
Table 11. Germany: Acute Lung Injury Market, by Therapy - Revenue and Forecast to 2028 (USD Million)
Table 12. Germany: Acute Lung Injury Market, by End User - Revenue and Forecast to 2028 (USD Million)
Table 13. France: Acute Lung Injury Market, by Therapy - Revenue and Forecast to 2028 (USD Million)
Table 14. France: Acute Lung Injury Market, by End User - Revenue and Forecast to 2028 (USD Million)
Table 15. UK: Acute Lung Injury Market, by Therapy - Revenue and Forecast to 2028 (USD Million)
Table 16. UK: Acute Lung Injury Market, by End User - Revenue and Forecast to 2028 (USD Million)
Table 17. Italy: Acute Lung Injury Market, by Therapy - Revenue and Forecast to 2028 (USD Million)
Table 18. Italy: Acute Lung Injury Market, by End User - Revenue and Forecast to 2028 (USD Million)
Table 19. Spain: Acute Lung Injury Market, by Therapy - Revenue and Forecast to 2028 (USD Million)
Table 20. Spain: Acute Lung Injury Market, by End User - Revenue and Forecast to 2028 (USD Million)
Table 21. Rest of Europe: Acute Lung Injury Market, by Therapy - Revenue and Forecast to 2028 (USD Million)
Table 22. Rest of Europe: Acute Lung Injury Market, by End User - Revenue and Forecast to 2028 (USD Million)
Table 23. Asia Pacific: Acute Lung Injury Market, by Therapy - Revenue and Forecast to 2028 (USD Million)
Table 24. Asia Pacific: Acute Lung Injury Market, by End User - Revenue and Forecast to 2028 (USD Million)
Table 25. China: Acute Lung Injury Market, by Therapy - Revenue and Forecast to 2028 (USD Million)
Table 26. China: Acute Lung Injury Market, by End User - Revenue and Forecast to 2028 (USD Million)
Table 27. Japan: Acute Lung Injury Market, by Therapy - Revenue and Forecast to 2028 (USD Million)
Table 28. Japan: Acute Lung Injury Market, by End User - Revenue and Forecast to 2028 (USD Million)
Table 29. India: Acute Lung Injury Market, by Therapy - Revenue and Forecast to 2028 (USD Million)
Table 30. India: Acute Lung Injury Market, by End User - Revenue and Forecast to 2028 (USD Million)
Table 31. South Korea: Acute Lung Injury Market, by Therapy - Revenue and Forecast to 2028 (USD Million)
Table 32. South Korea: Acute Lung Injury Market, by End User - Revenue and Forecast to 2028 (USD Million)
Table 33. Australia: Acute Lung Injury Market, by Therapy - Revenue and Forecast to 2028 (USD Million)
Table 34. Australia: Acute Lung Injury Market, by End User - Revenue and Forecast to 2028 (USD Million)
Table 35. Rest of Asia Pacific: Acute Lung Injury Market, by Therapy - Revenue and Forecast to 2028 (USD Million)
Table 36. Rest of Asia Pacific: Acute Lung Injury Market, by End User - Revenue and Forecast to 2028 (USD Million)
Table 37. Middle East and Africa: Acute Lung Injury Market, by Therapy - Revenue and Forecast to 2028 (USD Million)
Table 38. Middle East and Africa: Acute Lung Injury Market, by End User - Revenue and Forecast to 2028 (USD Million)
Table 39. Saudi Arabia: Acute Lung Injury Market, by Therapy - Revenue and Forecast to 2028 (USD Million)
Table 40. Saudi Arabia: Acute Lung Injury Market, by End User - Revenue and Forecast to 2028 (USD Million)
Table 41. South Africa: Acute Lung Injury Market, by Therapy - Revenue and Forecast to 2028 (USD Million)
Table 42. South Africa: Acute Lung Injury Market, by End User - Revenue and Forecast to 2028 (USD Million)
Table 43. UAE: Acute Lung Injury Market, by Therapy - Revenue and Forecast to 2028 (USD Million)
Table 44. UAE: Acute Lung Injury Market, by End User - Revenue and Forecast to 2028 (USD Million)
Table 45. Rest of Middle East and Africa: Acute Lung Injury Market, by Therapy - Revenue and Forecast to 2028 (USD Million)
Table 46. Rest of Middle East and Africa: Acute Lung Injury Market, by End User - Revenue and Forecast to 2028 (USD Million)
Table 47. South and Central America: Acute Lung Injury Market, by Therapy - Revenue and Forecast to 2028 (USD Million)
Table 48. South and Central America: Acute Lung Injury Market, by End User - Revenue and Forecast to 2028 (USD Million)
Table 49. Brazil: Acute Lung Injury Market, by Therapy - Revenue and Forecast to 2028 (USD Million)
Table 50. Brazil: Acute Lung Injury Market, by End User - Revenue and Forecast to 2028 (USD Million)
Table 51. Argentina: Acute Lung Injury Market, by Therapy - Revenue and Forecast to 2028 (USD Million)
Table 52. Argentina: Acute Lung Injury Market, by End User - Revenue and Forecast to 2028 (USD Million)
Table 53. Rest of South and Central America: Acute Lung Injury Market, by Therapy - Revenue and Forecast to 2028 (USD Million)
Table 54. Rest of South and Central America: Acute Lung Injury Market, by End User - Revenue and Forecast to 2028 (USD Million)
Table 55. Organic Developments Done by Companies
Table 56. Inorganic Developments Done by Companies
Table 57. Glossary of Terms, Acute Lung Injury MarketList of Figures
Figure 1. Acute Lung Injury Market Segmentation
Figure 2. Acute Lung Injury Market Segmentation, By Region
Figure 3. Global Acute Lung Injury Market Overview
Figure 4. Mechanical Ventilation Segment Held the Largest Share by Therapy in Acute Lung Injury Market
Figure 5. Asia Pacific to Show Significant Growth During Forecast Period
Figure 6. Acute Lung Injury Market, by Geography (US$ Million)
Figure 7. Global Acute Lung Injury Market- Leading Country Markets (US$ Million)
Figure 8. North America PEST Analysis
Figure 9. Europe and PEST Analysis
Figure 10. Asia Pacific PEST Analysis
Figure 11. Middle East and Africa PEST Analysis
Figure 12. South and Central America (SCAM) PEST Analysis
Figure 13. Acute Lung Injury Market Impact Analysis of Driver and Restraints
Figure 14. Global Acute Lung Injury Market- Revenue Forecast and Analysis - 2020- 2028
Figure 15. Global Acute Lung Injury Market - By Geography Forecast and Analysis - 2021- 2028
Figure 16. Market Positioning of Key Players in Global Acute Lung Injury Market
Figure 17. Acute Lung Injury Market Revenue Share, by Therapy (2021 and 2028)
Figure 18. Mechanical Ventilation: Acute Lung Injury Market - Revenue and Forecast to 2028 (US$ Million)
Figure 19. Fluid Management: Acute Lung Injury Market - Revenue and Forecast to 2028 (US$ Million)
Figure 20. Pharmacotherapy: Acute Lung Injury Market - Revenue and Forecast to 2028 (US$ Million)
Figure 21. Adjunctive Procedures: Acute Lung Injury Market - Revenue and Forecast to 2028 (US$ Million)
Figure 22. Acute Lung Injury Market Revenue Share, by End User (2021 and 2028)
Figure 23. Hospitals: Acute Lung Injury Market - Revenue and Forecast to 2028 (US$ Million)
Figure 24. Ambulatory Surgery Centers: Acute Lung Injury Market - Revenue and Forecast to 2028 (US$ Million)
Figure 25. Others: Acute Lung Injury Market - Revenue and Forecast to 2028 (US$ Million)
Figure 26. North America: Acute Lung Injury Market, by Key Country - Revenue (2021) (USD Million)
Figure 27. North America Acute Lung Injury Market Revenue and Forecast to 2028 (USD Million)
Figure 28. North America: Acute Lung Injury Market, by Country, 2021 & 2028 (%)
Figure 29. US: Acute Lung Injury Market - Revenue and Forecast to 2028 (USD Million)
Figure 30. Canada: Acute Lung Injury Market - Revenue and Forecast to 2028 (USD Million)
Figure 31. Mexico: Acute Lung Injury Market - Revenue and Forecast to 2028 (USD Million)
Figure 32. Europe: Acute Lung Injury Market, by Key Country - Revenue (2021) (USD Million)
Figure 33. Europe: Acute Lung Injury Market Revenue and Forecast to 2028 (USD Million)
Figure 34. Europe: Acute Lung Injury Market, by Country, 2021 & 2028 (%)
Figure 35. Germany: Acute Lung Injury Market - Revenue and Forecast to 2028 (USD Million)
Figure 36. France: Acute Lung Injury Market - Revenue and Forecast to 2028 (USD Million)
Figure 37. UK: Acute Lung Injury Market - Revenue and Forecast to 2028 (USD Million)
Figure 38. Italy: Acute Lung Injury Market - Revenue and Forecast to 2028 (USD Million)
Figure 39. Spain: Acute Lung Injury Market - Revenue and Forecast to 2028 (USD Million)
Figure 40. Rest of Europe: Acute Lung Injury Market - Revenue and Forecast to 2028 (USD Million)
Figure 41. Asia Pacific: Acute Lung Injury Market, by Key Country - Revenue (2021) (USD Million)
Figure 42. Asia Pacific: Acute Lung Injury Market Revenue and Forecast to 2028 (USD Million)
Figure 43. Asia Pacific: Acute Lung Injury Market, by Country, 2021 & 2028 (%)
Figure 44. China: Acute Lung Injury Market - Revenue and Forecast to 2028 (USD Million)
Figure 45. Japan: Acute Lung Injury Market - Revenue and Forecast to 2028 (USD Million)
Figure 46. India: Acute Lung Injury Market - Revenue and Forecast to 2028 (USD Million)
Figure 47. South Korea: Acute Lung Injury Market - Revenue and Forecast to 2028 (USD Million)
Figure 48. Australia: Acute Lung Injury Market - Revenue and Forecast to 2028 (USD Million)
Figure 49. Rest of Asia Pacific: Acute Lung Injury Market - Revenue and Forecast to 2028 (USD Million)
Figure 50. Middle East and Africa: Acute Lung Injury Market, by Key Country - Revenue (2021) (USD Million)
Figure 51. Middle East and Africa: Acute Lung Injury Market Revenue and Forecast to 2028 (USD Million)
Figure 52. Middle East and Africa: Acute Lung Injury Market, by Country, 2021 & 2028 (%)
Figure 53. Saudi Arabia: Acute Lung Injury Market - Revenue and Forecast to 2028 (USD Million)
Figure 54. South Africa: Acute Lung Injury Market - Revenue and Forecast to 2028 (USD Million)
Figure 55. UAE: Acute Lung Injury Market - Revenue and Forecast to 2028 (USD Million)
Figure 56. Rest of Middle East and Africa: Acute Lung Injury Market - Revenue and Forecast to 2028 (USD Million)
Figure 57. South and Central America: Acute Lung Injury Market, by Key Country - Revenue (2021) (USD Million)
Figure 58. South and Central America: Acute Lung Injury Market Revenue and Forecast to 2028 (USD Million)
Figure 59. South and Central America: Acute Lung Injury Market, by Country, 2021 & 2028 (%)
Figure 60. Brazil: Acute Lung Injury Market - Revenue and Forecast to 2028 (USD Million)
Figure 61. Argentina: Acute Lung Injury Market - Revenue and Forecast to 2028 (USD Million)
Figure 62. Rest of South and Central America: Acute Lung Injury Market - Revenue and Forecast to 2028 (USD Million)
Figure 63. Impact of COVID-19 Pandemic in North American Country Markets
Figure 64. Impact of COVID-19 Pandemic in European Country Markets
Figure 65. Impact of COVID-19 Pandemic on Asia Pacific Country Markets
Figure 66. Impact of COVID-19 Pandemic in Middle East and Africa Country Markets
Figure 67. Impact Of COVID-19 Pandemic in South and Central America Africa Country Markets
Figure 68. Growth Strategies Done by the Companies in the Acute Lung Injury Market, (%)
Companies Mentioned
- GlaxoSmithKline plc.
- Stemedica Cell Technologies, Inc
- Histocell
- APEPTICO Forschung und Entwicklung GmbH
- Windtree Therapeutics, Inc.
- ReAlta Life Sciences, Inc.
- Apeiron Biologics AG
- Qx Therapeutics, Inc.
- Angion
- Asklepion Pharmaceuticals, LLC
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 141 |
| Published | September 2021 |
| Forecast Period | 2021 - 2028 |
| Estimated Market Value ( USD | $ 539.61 Million |
| Forecasted Market Value ( USD | $ 741.98 Million |
| Compound Annual Growth Rate | 4.7% |
| Regions Covered | Global |
| No. of Companies Mentioned | 10 |
